We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 507

EEOC guidance spotlights pregnancy discrimination in the workplace

  • McGuireWoods LLP
  • -
  • USA
  • -
  • July 21 2014

With the passage of the Pregnancy Discrimination Act of 1978, Congress made it clear that discriminating against pregnant employees violates Title

New Florida Information Protection Act expands data breach notification requirements

  • McGuireWoods LLP
  • -
  • USA
  • -
  • July 3 2014

The Florida Information Protection Act of 2014 (FIPA), which became effective July 1, 2014, expanded the requirements on covered entities that

Weekly Washington healthcare update - July 21, 2014

  • McGuireWoods LLP
  • -
  • USA
  • -
  • July 21 2014

Hill hearings examine chronic illness, ACA eligibility systems... CMS launches next phase of quality improvement program... Wisconsin issues report

Weekly Washington healthcare update - July 14, 2014

  • McGuireWoods LLP
  • -
  • USA
  • -
  • July 14 2014

House and Senate committees explore Medicare payments... CMS releases updated report on Medicaid and CHIP enrollment...Congressional

Weekly Washington healthcare update

  • McGuireWoods LLP
  • -
  • USA
  • -
  • June 3 2013

On May 28, the Energy and Commerce Committee released a third draft of a proposal to overhaul Medicare's physician payment system. The panel has

Weekly Washington healthcare update - June 2, 2014

  • McGuireWoods LLP
  • -
  • USA
  • -
  • June 3 2014

Energy and Commerce approves public health bills related to autism, drug diversion... FDA Appropriations bill approved by full committee... CDC

Drug Quality and Security Act: what you need to know

  • McGuireWoods LLP
  • -
  • USA
  • -
  • December 4 2013

In recent years, Congress and the Food and Drug Administration (FDA) have worked on several legislative measures designed to address weaknesses in

Recent FDA warning to 23andMe tightens grasp on personal genomic sequencing

  • McGuireWoods LLP
  • -
  • USA
  • -
  • December 10 2013

FDA's recent warning letter to 23andMe, the largest and best-known company offering direct-to-consumer genetic testing, highlights the challenges

Investing in dental practice management: key issues and notable transactions

  • McGuireWoods LLP
  • -
  • USA
  • -
  • October 23 2012

The dental practice management model has become an increasingly popular investment vehicle with management companies and private equity firms

Drugs made by compounders that operate in violation of the food, drug, and cosmetic act create recoupment risk

  • McGuireWoods LLP
  • -
  • USA
  • -
  • February 10 2014

The U.S. Department of Health and Human Services Office of Inspector General's (OIG) Work Plan for Fiscal Year 2014 indicates that the OIG will be